Zhejiang Chimin Pharm Co Ltd (603222) — Tangible Net Worth Ratio
Zhejiang Chimin Pharm Co Ltd (603222) has a Tangible Net Worth Ratio of 83.8% as of June 2026. This metric is calculated by deducting intangible assets (CN¥190.03 Million) from net assets (CN¥1.17 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore Zhejiang Chimin Pharm Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Zhejiang Chimin Pharm Co Ltd Tangible Net Worth Ratio (2011–2025)
This chart shows how Zhejiang Chimin Pharm Co Ltd's Tangible Net Worth Ratio has changed across 15 annual periods from 2011 to 2025. As of June 2026, the ratio stands at 83.8%, reflecting net assets of CN¥1.17 Billion with intangible assets of CN¥190.03 Million CNY. For live market cap and overall valuation, see Zhejiang Chimin Pharm Co Ltd stock valuation.
Annual Tangible Net Worth Ratio for Zhejiang Chimin Pharm Co Ltd (2011–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Zhejiang Chimin Pharm Co Ltd from 2011 to 2025, covering 15 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore capital reinvestment ratio of Zhejiang Chimin Pharm Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 85.2% | CN¥1.31 Billion | CN¥193.38 Million | CN¥2.31 Billion | ▼ -1.9 pp |
| 2024 | 87.1% | CN¥1.57 Billion | CN¥202.93 Million | CN¥2.41 Billion | ▼ -0.2 pp |
| 2023 | 87.3% | CN¥1.66 Billion | CN¥211.05 Million | CN¥2.48 Billion | ▼ -0.4 pp |
| 2022 | 87.7% | CN¥1.77 Billion | CN¥218.94 Million | CN¥2.71 Billion | ▲ +3.5 pp |
| 2021 | 84.2% | CN¥1.37 Billion | CN¥217.33 Million | CN¥2.43 Billion | ▲ +5.4 pp |
| 2020 | 78.8% | CN¥1.05 Billion | CN¥222.30 Million | CN¥2.29 Billion | ▼ -1.1 pp |
| 2019 | 79.8% | CN¥1.07 Billion | CN¥216.53 Million | CN¥2.08 Billion | ▲ +4.2 pp |
| 2018 | 75.6% | CN¥1.05 Billion | CN¥255.26 Million | CN¥2.12 Billion | ▼ -0.2 pp |
| 2017 | 75.8% | CN¥928.28 Million | CN¥224.25 Million | CN¥1.57 Billion | ▼ -3.6 pp |
| 2016 | 79.4% | CN¥808.94 Million | CN¥166.50 Million | CN¥922.43 Million | ▼ -8.8 pp |
| 2015 | 88.2% | CN¥750.99 Million | CN¥88.62 Million | CN¥844.01 Million | ▲ +8.7 pp |
| 2014 | 79.5% | CN¥441.55 Million | CN¥90.69 Million | CN¥630.04 Million | ▼ -1.6 pp |
| 2013 | 81.1% | CN¥488.13 Million | CN¥92.26 Million | CN¥713.38 Million | ▲ +3.0 pp |
| 2012 | 78.1% | CN¥432.53 Million | CN¥94.70 Million | CN¥690.63 Million | ▲ +3.4 pp |
| 2011 | 74.7% | CN¥383.04 Million | CN¥96.90 Million | CN¥655.30 Million | — |